WHO publishes Draft Working Document on Chromatography
Recommendation

Thursday, 3 September 2026 9 .00 - 17.00 h
Establishment, Use and Maintenance of Analytical Reference Substances
The World Health Organization (WHO) has published a draft proposal for inclusion in The International Pharmacopoeia. The new chapter 1.14.1 Chromatography shall replace the chapters 1.14.1 Thin-layer chromatography, 1.14.4 High-performance liquid chromatography and 1.14.5 Gas Chromatography.
The first draft working document was prepared based on the internationally-harmonized text developed by the Pharmacopoeial Discussion Group (PDG).
The following aspects are covered:
- Introduction: The introduction contains a short section on the definition of chromatography.
- Definitions: The section contains definitions and calculations of common parameters, e.g.
- Distribution constant
- Dwell volume
- Peak-to-valley ratio
- Plate height
- Plate number
- Relative retardation
- Resolution
- Separation factor
- Signal-to-noise ratio
- Symmetry factor
- System repeatability - System suitability: In this section, generally applicable requirements for system suitability are given. Only liquid chromatography and gas chromatography are covered.
- Adjustment of chromatographic conditions: The extent to which the various parameters of a chromatographic test may be adjusted without fundamentally modifying the pharmacopoeial analytical procedures are listed.
- Quantitation: The quantitation approaches that may be used in general texts or monographs are described.
- Other considerations: The new chapter concludes with some general aspects on
- Detector response
- Interfering peaks
- Measurement of peaks
- Reporting threshold
The draft working document (QAS/21.905) is available as a PDF file on the WHO homepage. Comments can be submitted until 25 March 2022.
Related GMP News
01.07.2026Several FDA Warning Letters and Untitled Letters on Asbestos Testing of Talc in OTC Drug Products
24.06.2026Analytical Quality Group Developments January through April 2026
17.06.2026BioPhorum Publishes a Roadmap for QC Sample Test Execution
03.06.2026EMA Provides an Outlook on the Product-Specific Bioequivalence Guidelines Expected in 2026
03.06.2026FDA Warning Letter: Missing Method Validation - From a QC Topic to a Market-Access Problem
28.05.2026WHO Working Document on Bioequivalence open for Public Consultation


